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Engineering a multimodal nerve conduit for repair of injured peripheral nerve 
Abstract 
Injury to nerve tissue in the peripheral nervous system (PNS) results in long-term impairment of limb 
function, dysaesthesia and pain, often with associated psychological effects. Whilst minor injuries can be 
left to regenerate without intervention and short gaps up to 2 cm can be sutured, larger or more severe 
injuries commonly require autogenous nerve grafts harvested from elsewhere in the body (usually 
sensory nerves). Functional recovery is often suboptimal and associated with loss of sensation from the 
tissue innervated by the harvested nerve. The challenges that persist with nerve repair have resulted in 
development of nerve guides or conduits from non-neural biological tissues and various polymers to 
improve the prognosis for the repair of damaged nerves in the PNS. This study describes the design and 
fabrication of a multimodal controlled pore size nerve regeneration conduit using polylactic acid (PLA) 
and (PLA):poly(lactic-co-glycolic) acid (PLGA) fibers within a neurotrophin-enriched alginate hydrogel. The 
nerve repair conduit design consists of two types of PLGA fibers selected specifically for promotion of 
axonal outgrowth and Schwann cell growth (75:25 for axons; 85:15 for Schwann cells). These aligned 
fibers are contained within the lumen of a knitted PLA sheath coated with electrospun PLA nanofibers to 
control pore size. The PLGA guidance fibers within the nerve repair conduit lumen are supported within an 
alginate hydrogel impregnated with neurotrophic factors (NT-3 or BDNF with LIF, SMDF and MGF-1) to 
provide neuroprotection, stimulation of axonal growth and Schwann cell migration. The conduit was used 
to promote repair of transected sciatic nerve in rats over a period of 4 weeks. Over this period, it was 
observed that over-grooming and self-mutilation (autotomy) of the limb implanted with the conduit was 
significantly reduced in rats implanted with the full-configuration conduit compared to rats implanted with 
conduits containing only an alginate hydrogel. This indicates return of some feeling to the limb via the 
fully-configured conduit. Immunohistochemical analysis of the implanted conduits removed from the rats 
after the four-week implantation period confirmed the presence of myelinated axons within the conduit 
and distal to the site of implantation, further supporting that the conduit promoted nerve repair over this 
period of time. This study describes the design considerations and fabrication of a novel 
multicomponent, multimodal bio-engineered synthetic conduit for peripheral nerve repair. 
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Abstract 
Injury to nerve tissue in the Peripheral Nervous System (PNS) results in long-term impairment of 
limb function, dysaesthesia and pain, often with associated psychological effects. Whilst minor 
injuries can be left to regenerate without intervention and short gaps up to 2 cm can be sutured, larger 
or more severe injuries commonly require autogenous nerve grafts harvested from elsewhere in the 
body (usually sensory nerves). Functional recovery is often suboptimal and associated with loss of 
sensation from the tissue innervated by the harvested nerve. The challenges that persist with nerve 
repair have resulted in development of nerve guides or conduits from non-neural biological tissues 
and various polymers to improve the prognosis for the repair of damaged nerves in the PNS. This 
study describes the design and fabrication of a multimodal controlled pore size nerve regeneration 
conduit using polylactic acid (PLA) and (PLA):poly(lactic-co-glycolic) acid (PLGA) fibers within a 
neurotrophin-enriched alginate hydrogel. The Nerve Repair conduit design consists of two types of 
PLGA fibers selected specifically for promotion of axonal outgrowth and Schwann cell growth 
(75:25 for axons; 85:15 for Schwann cells). These aligned fibers are contained within the lumen of a 
knitted PLA sheath coated with electrospun PLA nanofibers to control pore size. The PLGA 
guidance fibers within the nerve repair conduit lumen are supported within an alginate hydrogel 
impregnated with neurotrophic factors (NT-3 or BDNF with LIF, SMDF and MGF-1) to provide 
neuroprotection, stimulation of axonal growth and Schwann cell migration. The conduit was used to 
promote repair of transected sciatic nerve in rats over a period of 4 weeks. Over this period, it was 
observed that over-grooming and self-mutilation (autotomy) of the limb implanted with the conduit 
was significantly reduced in rats implanted with the full-configuration conduit compared to rats 
implanted with conduits containing only an alginate hydrogel. This indicates return of some feeling 
to the limb via the fully-configured conduit. Immunohistochemical analysis of the implanted conduits 
removed from the rats after the four-week implantation period confirmed the presence of myelinated 
axons within the conduit and distal to the site of implantation, further supporting that the conduit 
promoted nerve repair over this period of time. This study describes the design considerations and 
fabrication of a novel multicomponent, multimodal bio-engineered synthetic conduit for peripheral 
nerve repair. 
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Introduction 
Peripheral nerve (PN) damage causes loss of sensation and function in target organs ranging in 
severity from mild to severe incapacitation. Estimates from retrospective studies indicate that every 
year, more than one million people in the US suffer serious PN injuries arising from lower limb 
trauma alone [1], and that over 50,000 surgical procedures are performed on a yearly basis to correct 
injured PN[2]. The incidence of neuropathies or nerve dysfunction due to other pathological 
processes such as diabetes [3;4] furthers the impact of PN injury as a major human health issue.  
 
Varying degrees of nerve injury sub-classified at the fiber level, range from partial injuries, where 
there is temporary interruption to nerve transmission, complete interruption of transmission but with 
the nerve still intact, to the nerve being completely severed [5], and require different approaches to 
repair: Minor injuries, particularly to smaller monofascicular nerves in the peripheral nervous system 
(PNS), can regenerate without intervention whilst short gaps up to 2 cm can be repaired directly by 
suturing [6-8], Larger or more severe injuries however, are commonly treated by autogenous nerve 
grafts harvested from elsewhere in the body (usually sensory nerves). Such autografts restore some 
function, but are associated with loss of sensation in the tissue innervated by the harvested nerve[9].  
 
Significant attention has thus been directed towards development of nerve guides or conduits based 
on allografts, xenografts and various bioresorbable or non-resorbable synthetic polymers in order to 
improve the prognosis for repair of damaged nerves in the PNS and avoid the loss of neural function 
caused by harvesting sensory nerve autografts [10-18]. Universally, the design of such nerve repair 
conduits aims to facilitate a neurotrophic environment that allows proper growth and reconnection of 
regenerating (damaged) axons with the distal end of the damaged nerve. This has resulted in the 
incorporation of a wide variety of materials, fabrication processes and trophic agents to produce the 
most effective nerve repair conduits: These include polymers such as collagen, poly-lactides, 
alginate, fibrin, keratin, chitin, Teflon (PTFE), spider silk and silicone [19;20], in addition to 
biological tissue-based materials including nerve, blood vessels and amniotic tubes [21-23]. Materials 
have been incorporated into nerve repair conduits as electrospun webs [13], fibers [24], sponges [25] 
and hydrogels [26]. Some positive results have been demonstrated with some of these materials in 
animals and in some case in humans, however efficacy remains variable [27;28]. In general, nerve 
repair conduits are still inferior in performance compared to the autogenous nerve graft [29]. It is 
nevertheless accepted that with further improvement, synthetic nerve guides provide an alternative 
for nerve repair [29]. In particular, use of synthetic conduits affords the major advantage that nerves 
once thought to be low priority for autograft (eg in the far periphery) due to their requirement of 
donor nerve from other regions, can be repaired without loss of sensation or function in “more 
important” regions of the body [30]. Likewise, conduits provide an alternative for the treatment of 
acquired nerve defects such as diabetic neuropathy [31].  
 
Nevertheless, there are still considerable challenges and room for improvement for the use of 
synthetic conduits for nerve repair, particularly for longer nerve repair applications [32]. 
Improvement of nerve repair guides has mainly focused on the incorporation of trophic factors [33], 
such as Neurotrophin-3 (NT-3) [34], Brain-Derived Neurotrophic Factor (BDNF) [35] Leukemia 
Inhibitory Factor (LIF) [36-39], and Glial Growth Factor (GGF) [40]. In addition, a number of 
studies have incorporated extracellular matrix proteins, such as laminin and collagen resulting in 
improved nerve repair [25;41]. However, little attention has been paid to date as to the inherent pro-
neural properties as opposed to the more generalized “biocompatibility” of the specific materials 
from which the conduits are made. As a consequence of this, the small number of commercially-
available conduits based on individual extracellular matrix proteins such as type I collagen (e.g. 
NeuraGen) have shown limited ability to support nerve regeneration and fail to confer the 
regenerative advantages achieved with nerve isografts in animals [42]. This sub-optimal capacity to 
support nerve regeneration, most likely due to the fact that current conduits do not accurately reflect 
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the specific extracellular matrix of nerve, is highlighted by the fact that autogenous nerve grafts are 
still considered the “gold standard” of nerve repair and favoured by neurosurgeons, despite the 
commercial availability of “off the shelf” conduits [43].  
 
Finally, advances in polymer fabrication technologies in recent times has enabled the fabrication of 
scaffolds with combined therapeutic modalities, as highlighted by co-incorporation of GGF and 
Schwann cells within a nerve repair conduit [44]. Multimodal delivery of bio-activities that 
individually target specific aspects of nerve repair using engineered conduits composed of multiple, 
likewise bio-selective materials to compartmentalize desired aspects of nerve repair and limit 
inhibitory activity, have great potential to improve surgical outcomes in nerve repair surgery. 
 
This study communicates the design, experimental development and fabrication of a multimodal 
controlled pore size nerve regeneration conduit using polylactic acid (PLA) and poly(lactic-co-
glycolic) acid (PLGA) fibers within a neurotrophin-enriched alginate hydrogel for the promotion of 
nerve repair in an axotomized rat sciatic nerve. The Nerve Repair conduit design consists of two 
types of PLGA fibers selected specifically for their inherent promotion of Schwann cell growth 
primarily, and axonal outgrowth, with a secondary promotioin of axonal growth activity in preference 
to fibroblasts. These fibers are contained within the lumen of a knitted PLA sheath overlaid with 
electrospun PLA nanofibers to control pore size. The PLGA guidance fibers within the neural repair 
lumen are supported within an alginate hydrogel impregnated with neurotrophic factors (NT-3 with 
LIF, SMDF and MGF-1) for neuroprotection, stimulation of axonal growth and Schwann cell 
migration. This study describes a novel multimodal bio-engineered conduit for promotion of 
peripheral nerve repair. 
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Methods 
Polymer Formulations and Configurations: 
Polymers for Biocompatibility Assays: 
Eight formulations of Polylactic Acid (PLA) and Poly-DL-lactide/glycolide copolymers (PLGA) 
polymers were selected on their commercial availability and regulatory body (FDA) approval for use 
in humans. Polylactic acid 3051D (PLA) was obtained from Natureworks. PLGA copolymers were 
obtained from Purac Biomaterials. The grades of PLGA used were Purasorb PDLG 85:15 DL-
lactide/glycolide copolymer (inherent viscosity (i.v.) 0.84 dl/g), Purasorb PDLG 75:25 DL-
lactide/glycolide copolymer (i.v. 0.93 dl/g) and Purasorb PDLG 50:50 DL-lactide/glycolide 
copolymer with i.v. values of 0.17, 0.37, 0.59, 1.05 dl/g. Lactel PLGA 50:50 ester terminated with 
i.v. 0.76-0.94 dL/g was obtained from from Durect Corporation, Pelham, AL, USA.. 
 
For evaluation of relative cytocompatibility for the various cell types, each polymer formulation was 
prepared as a 2% (w:v) solution in chloroform and drop-cast in 100 µl volumes into wells of 96-
chamber microtitre plates. The chloroform was evaporated off in a fume hood overnight. The dried 
polymers were sterilized using 70% ethanol (20 min) which was then removed and allowed to dry off 
for 4 hrs under laminar flow prior to serial (5 times) washing and equilibration in cell growth media.  
 
Evaluation of Cytocompatibility and Cell Affinity for PLGA Formulations: 
In order to facilitate 'standardization' and more uniform comparability of cell response to the 
polymers, cell lines were used in preference to primary cultures. To evaluate each polymer's relative 
cytocompatibility and facilitation of cell growth, for each cell type, polymer formulations were drop 
cast (100 µl of 2% polymer in chloroform) in triplicate into 96 well plates. Cell-seeding densities of 
between 100 and 104 cells per assay were used and measured by absorbance (A490) of formazan 
product arising from the cytoplasmic reductase-mediated reduction of MTS reagent (3-[4,5-
dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium) and the 
electron coupling PMS (phenazine methosulfate) using the CellTiter 96 AQueous Non-Radioactive 
Cell Proliferation Assay (Promega). This avoided cell visibility issues caused by the porosity and 
opacity of the polymer formulations that arise using standard cell counting methods.  
 
Cells were allowed to adhere to the various polymer formulations, over 72 hours (6, 24, and 72 
hours) to determine the polymer with the best adhesion and biocompatibility facilitation for each 
respective cell type. Differences in the empirical amounts of reductase activity (as measured by 
MTS) cell number in the PC12, RSC96 and Rat1-R12 cells (all purchased from the American Type 
Culture Collection; ATCC) were calibrated by comparison of known numbers of each respective cell 
type (100, 1000, 5000 and 10,000 cells): After correction for background absorbance, RSC96 cells 
(5000 cells) returned the highest A490, (0.671) followed by the Rat1-R12 (0.551) and then the PC12 
cells (0.484). These data provided the calibration factors for subsequent MTS data to enable direct 
comparison of relative cell numbers via the MTS data: All subsequent absorbance data were 
expressed relative to RSC96 using calibration multipliers of 1.39 (PC12), 1.00 (RSC96) and 1.22 
(Rat1-R12) that were applied to normalize the MTS readings for comparison of relative cell numbers 
between the different cell types. Early attachment (after 6 hrs), primary (24 hrs) and established (72 
hrs) proliferative attachment  were scored, calibrated (as above) and compared for each respective 
cell type on each polymer formulation evaluated. The data were subjected to statistical analysis using 
two-tailed Fisher’s student t statistic for unpaired samples with unequal variance to establish the 
statistical significance of differences observed between the test groups. 
 
PC12 (Neural), RSC96 (Schwann) and Rat1-R12 (Fibroblast) Cell Lines Culture: 
PC12, RSC96 and Rat1-R12 cells were grown in growth media containing DMEM with 4 mM 
glutamine, 4.5g/L glucose, 1.5g/L sodium bicarbonate, 100 g/ml streptomycin, 100U/ml penicillin, 
10% Fetal Calf Serum (FCS) or 5% Horse Serum (for PC12s only) with media changes every 2nd 
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day. When sufficient cells were grown for experimentation, they were detached from tissue culture 
flasks using dissociation buffer containing 0.25% trypsin for 5 minutes at 37°C and transferred to 96 
well microtitre plates with respective polymer formulations drop cast in the wells as outlined above. 
 
After sterilization and equilibration of the polymer formulations, 1x104 PC12, RSC96 and Rat1-R12 
cells were applied to each well in 100 µl volume triplicates with growth media (as above).  The cells 
were then incubated at 37oC (media changes every 2nd day) in a humidified tissue culture (TC) 
incubator, for the appropriate period of time.  The floating cells were removed, and polymers/cells 
washed twice in TC media before cell assay reagent (Promega AQeous MTS) was added to the cells, 
according to manufacturer specification.  Cells were incubated with assay reagent for 4 hours in a TC 
incubator, before absorbance measurements (adjusted for background), were taken at 490nm. Values 
were adjusted for background and calibrated to normalize for metabolic differences and expressed as 
mean ± s.e.m. Statistical analyses were carried out using two-tailed Fisher’s student t statistic for 
unpaired samples with unequal variance. 
 
Effects of Microfibers on Axonal Guidance and Schwann Cell Migration from DRG: 
Whole Dorsal Root Ganglia (DRG) explants were used to assess the effect of miscrostructure on  
axonal sprouting (neurite outgrowth) and guidance and Schwann cell migration on fibers formed 
from appropriately selected polymers. After hypothermia induced anaesthesia, 2-4 day old rat pups 
rat pups were euthanased and decapitated.  The spinal cord was removed and discarded to expose the 
underside of the spinal column. Whole DRG were removed from the side of the spinal column using 
fine tweezers and placed into 1 x Hank’s Balanced Salt Solution (HBSS; Invitrogen). 
 
The two biodegradable poly (DL-lactic-co-glycolic acid) co-polymer formulations (75:25 PLGA, 
0.71 i.v., 110,000 Da and 85:15 PLGA, 0.84 i.v., 135,000 Da) determined to be optimal for axonal 
and Schwann cell growth respectively were wet-spun into fibers approximately 30 µm in diameter as 
described below on gold mylar substrata. The entire microstructured assembly[45;46]  was overlaid 
with a four-chambered polypropylene chamber slide assembly for analysis of axonal growth and 
Schwann cell migration guidance by the fibers  as described elsewhere[45] to allow for rapid iterative 
cycles of evaluation and adjustment: Briefly, a solution of the selected polymer formulations in 
chloroform was injected into a 1.5 cm-diameter tube filled with the coagulation solvent in a one 
metre long coagulation bath. The fibers were then collected around a collector spool containing pre-
washed (with ethanol) mylar or gold-coated mylar substrata. The spinning solution injection rate and 
the fiber collection speed were controlled at 1.8 ml/hr and 8.5 m/min, respectively, resulting in fibers 
of 30 um cross-sectional diameter. For this study, isopropanol was used as coagulation and wash 
solutions. After initial establishment of microstructure effects on a two-dimensional platform, the 
effect of micro-structured matrix on primary DRG explants was evaluated in a polypropylene tube (2 
mm ID) containing PLGA fibers inserted into supporting alginate gel matrices. Fibers for the 
finalized conduit assembly were then formed using hot melt extrusion, which allowed the generation 
of larger lengths and quantities of fibers than did the wet-spinning process. 
 
For DRG attachment, the substrata within the chambers were coated with 0.02 mg/ml laminin 
(Gibco; diluted in Hank’s balanced salt solution; HBSS) by incubation at 37oC for 2 hr after which 
they were rinsed twice with HBSS to remove excess laminin. DRG were placed into the chamber 
slides with appropriate microstructured substrata (as described in preceding text) containing DRG 
growth media (Neurobasal A containing 1 x B27, 4 mM L-glutamine, 1 x penicillin/streptomycin) 
and incubated at 37oC in humidified 5% CO2. The DRG were allowed to attach onto the 
microstructured PLGA/Laminin [45;46] platforms for three days, with attachment confirmed by 
removal of media and mild rinsing with HBSS. DRG that remained attached after the rinses were 
then grown for a 30-day period with media changes every two days to evaluate the effect of the 
microfibers on axonal outgrowth and Schwann cell migration from the DRG explant body. Axons 
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were visualized by immunohistochemical staining for βIII Tubulin, Schwann cells with S100β and 
cell nuclei (Schwann cells and fibroblasts) with DAPI as described below. Cells staining positive for 
DAPI, but negative for either βIII Tubulin or S100β were assigned to be non-neural Fibroblast cells. 
 
Immunohistochemistry: 
Polymer Biocompatibility/Optimization: Cell adherence to each polymer sample was validated by 
staining and visualization of cell nuclei. At each time point the culture media were removed and the 
polymer samples washed twice by slow immersion in 0.5ml PBS.  Adherent cells (cells remaining) 
were fixed in 4% paraformaldehyde for 15 min at room temperature. Cells were then stained with 
DAPI (Sigma) for 10 min at room temperature to allow visualization.  Photomicrographs of 5 
representative fields of view on each polymer disc were taken under UV fluorescence using an 
Olympus IX70 inverted microscope and liquid-cooled CCD digital camera (SPOT Diagnostics RT-
Slider).   
 
Relative Axonal, Schwann Cell and Fibroblast Growth: After removal of culture media, the growth 
platform was washed twice by slow immersion in 0.5ml PBS. The cells were fixed in 4% 
paraformaldehyde for 15 min at room temperature. After fixation, the scaffolds were incubated in 
10% donkey serum (Chemicon) for 1 hour at room temperature. The scaffolds were then incubated 
with both rabbit anti-βIII Tubulin (1:1,000 dilution, Covance) and mouse anti-S100β (1:2,000 
dilution, Sigma) at 37oC for 1 hour to visualize neuronal growth and Schwann cell migration 
respectively from the DRG.  After incubation, the primary antibodies were removed and scaffolds 
washed in 1 x PBS, before incubation at 37oC for 1 hour with alexafluor donkey anti-rabbit and 
donkey anti-mouse secondary antibodies (Molecular Probes; both at 1:2,000 dilution) in 10% donkey 
serum. The secondary antibodies were then removed, scaffolds washed once in PBS for 5 minutes 
and stained with DAPI (200 ng/ml) for 15 minutes at room temperature. The scaffolds were then 
placed in a 6 well dish for visualization and photomicrography. 
 
Conduit Development and Fabrication:  
In vitro experiments indicated that the 75:25 and 85:15 PLGA formulations were optimal for use as 
fibers within the proposed conduit lumen. In addition, the PLA polymer was selected as the material 
for the outer wall of the conduit due to its comparatively robust nature compared to the other 
polymers evaluated. The design for the nerve conduit sheath incorporated a knitted tube, providing 
appropriate mechanical properties to the conduit, with an electrospun membrane dictating the 
construct’s permeability to trophic environmental factors and external cells. Guidance fibers were set 
in a trophic hydrogel within the lumen of the conduit. Stage-wise fabrication of the conduit involved 
production of the knitted tube with electrospun outer membrane, (pore size <2 µm). The conduit was 
then filled with 75:25 and 85:15  melt-extruded PLGA fibers, and an alginate hydrogel containing 
growth factors for the promotion of axonal sprouting and Schwann cell development throughout the 
conduit. 
 
Melt Extrusion of Fibers:  
Previous studies [47] found improved neurite outgrowth and Schwann cell migration along 30μm 
diameter polypropylene fibres, compared to larger fibres (100-500 μm). Fibers for knitted sheath 
fabrication and for incorporation as axonal guidance fibers used PLGA formulations (Purac). PLA, 
PLGA 75:25 and 85:15 were dried to <20ppm water content using a dehumidifyer at 80oC overnight. 
The polymers were then cryo-ground to a powder to enable accurate feeding into the extruder. 
Polymers were fed at a rate between 0.3 to 1 g/min into a twin screw extruder (Prism Eurolab 16) 
fitted with a gear pump (Barrell) and heated from 175oC to 195oC at the rod die (0.3mm). The 
extrudate fibres were air-cooled and the fiber diameter and morphology was controlled via a godet 
system of heated and unheated rollers (Retech) incorporated into the extrusion line. Fiber diameters 
were determined by optical and scanning electron microscopy.  These extruded fibers, of diameter 90 
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to 100um were used for knitting the outer sheath and extruded fibers with 30-40 um diameter were 
used as nerve guidance fibers within the sheath lumen. 
 
Knitting and Electrospin-Coating of the Conduit Sheath: 
The conduit sheaths were knitted as a circular tube, with an internal diameter of 2 mm, from extruded 
PLA monofilament yarn of 90 to 100 µm diameter, using a Harry Lucas circular knitting machine 
1/12 inch diameter over five needles (approx. fifteen needles per inch). PLA nanofibers were 
electrospun onto the knitted sheath to generate a “membrane” of controlled pore size, with pores no 
greater than, 2 µm in diameter. Pores of this size have been found by others to be beneficial to nerve 
regeneration in vivo [48] and are of sufficiently small size to exclude entry of cells through the sheath 
wall. PLA nanofibers were deposited onto the knitted sheath by mounting the sheath through its 
lumen onto a grounded stainless steel collector rod. The rod was tilted to ensure a random deposition 
of the electrospun layer, and connected to a variable-speed motor. PLA (15% w/w) in chloroform 
was electrospun onto the sheath using 15 cm distance to target and an applied electric field of  20 kV 
at a solution feed rate of 0.2 ml/hr. This resulted in an interconnected membrane of PLA nanofibers, 
with a large surface area per unit mass ratio.  
 
Multimodal Alginate Neuromatrix: 
Cross-linked alginate has been shown to be a suitable matrix for the promotion of nerve repair in 
early studies [36;37] and was selected on this basis as the primary matrix material for the 
nueromatrix component of the conduit. In the first instance, whole DRG explants were used to test 
the capacity of alginate to support neurite outgrowth and Schwann cell migration from the main body 
of the DRG: Several formulations of alginate (0.5–1.5% alginate) were cross linked with CaCO3 to 
establish optimal gel densities for the promotion of nerve growth (data not shown). Filter sterilized 
alginate was cross linked either in petri dishes or in sterile glass vials for DRG explant culture growth 
analysis.  
 
The specific modalities and molecular pathway utilization  of several neurotrophins and trophic bio-
factors provide good rationale for the design of an augmentative synergistic multi-modal neuro-
regenerative function that elicits neurogenic or otherwise neurotrophic effects by enlisting several 
independent neurotrophic pathways:  Neurotrophin-3 (NT-3) [34], Brain-derived Neurotrophic factor 
(BDNF) [12;35], a 24 residue peptide of the Insulin-derived Growth Factor 1E (IGF-1Eb) splice 
variant (Mechano Growth Factor-1 MGF-1) [49-51], Neuregulin 1 isoform, Sensory and Motor 
Neuron-Derived Factor (SMDF) [52;53] and Leukaemia Inhibitory Factor (LIF) [36;37] were 
specifically selected as components within the conduit hydrogel on this basis:- NT-3 promotes 
neurogenesis via TrkC with secondary activation through TrkA and TrkB pathways, whilst BDNF 
works through TrkB receptor pathways. Both of these neurotrophins are factors implicated in sensory 
and motor neuromuscular junction formation at muscle spindles and otherwise as potent 
neuroprotective agents compared to other neurotrophins.[54;55] LIF promotes survival of injured 
motor neurons through activation of the gp130 receptor pathway, similar to other neuropoietic 
cytokines such as ciliary neurotrophic factor (CNTF) but with more defined neurotrophic 
effects.[55;56] SMDF is highly expressed in motor and sensory neurons[57] and indirectly promotes 
neurotrophic effects through stimulation of Schwann cell growth via epidermal growth factor 
receptor (EGFR) pathways.[52;53] MGF-1 has been shown to promote neurotrophic effects, 
particularly on motor neurons via an as-yet uncharacterized receptor pathway distinct from that of 
IGF-1.[49;58;59] 
 
The multimodal neuromatrix’ specific biofactor constitution was developed independently by 
inclusion of each respective sub-component in amounts ranging between 1 and 200 ng/ml into 
dissociated DRG sensory neuron cultures in vitro to evaluate the optimal growth factor configuration 
for ultimate incorporation into the conduit: In the first instance, working concentrations of each of 
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these bio-factors were optimized individually using dissociated DRG pseudo-bipolar sensory neurons 
and the extent of axonal outgrowth measured and analysed microscopically using NeuronJ 
software[60] in a minimum of 500 independent neurons distributed throughout biological triplicate 
(neurons derived from 3 separate animals) experiments to determine their most effective 
concentrations. These data were then pooled and statistically analysed using the student t statistic 
(two-tailed, equal variance, unpaired samples) to determine the multimodal mixture that would result 
in the best synergistic neuro-regenerative response (Table 1).    
 
Development and Testing of Inner Neuromatrix Conduit Core ex vivo:   
The two most effective potential multimodal mixtures (NT-3 and BDNF configurations with MGF-1, 
SMDF and LIF) were then used to grow whole DRG ex vivo in polyethylene (PE) tubing with a 2 
mm inner diameter (Accurel, Akzo Chemicals Limited) designed to simulate the conduit 
environment, containing 0.75% alginate with 75:25 and 85:15 PLGA fibers and each respective 
multimodal neurotrophic mixture in order to confirm the in vitro dissociated DRG neuron results. 
Alginate containing one of the two “optimal” combinations of the proposed biofactors was cross-
linked inside the lumen of the polyethylene (PE) tubing with an internal diameter of 2 mm (diameter 
of the rat sciatic nerve). PLGA fibers were included in some of these PE tubes, whilst other tubes 
contained hydrogel alone to evaluate the effect of the fibers on DRG neuronal growth compared to 
growth in the absence of fibers. DRG of similar size between individual applications were placed 
inside the polyethylene tubing, partially withdrawn from the tube and trimmed after the neuromatrix 
formulations had set, to accommodate the placement of the DRG. The tubing, containing alginate 
neuromatrix formulations, combinations of 85:15 and 75:25 PLGA fibers and DRG were placed in 
24-well plates and covered with DRG growth media containing Neurobasal A (Invitrogen), 1 x B27 
supplement (Invitrogen), 2 mM L-Glutamine (Invitrogen) and 100 units/ml Penicillin and 100µg/ml 
/Streptomycin (Invitrogen). The DRG were then allowed to grow as described above for 2-3 weeks 
(with media changes every two days) at which point they were harvested and analysed for neuronal 
outgrowth and Schwann cell migration. DRG growth dynamics were assessed using DAPI staining to 
visualize Schwann cell growth as an overall measurement of DRG nerve growth incursion into the 
matrix along the fibers which was measured (within the limitations imposed by the opacity of the PE 
capillaries) under microscopy using a graticule. In conjunction with the dissociated DRG neuron 
experiments, this provided a confirmatory basis by which the optimal neuromatrix composition was 
determined for incorporation into the conduit design.   
 
In addition to biofactor and alginate composition of the hydrogel, the number of fibers to be placed 
within the lumen was investigated by this method. Others have previously reported that packing 
densities (using approx. 50 µm PLA fibers within a 1.5 mm internal diameter silicone cuff) of 
between 3.5 and 7.5% internal surface area packing densities yielded the most effective repair, but 
that the higher density resulted  in more uniform placement of the fibers within the cuff lumen [61]. 
In our study, PE tubes were loaded with 150, 300, and 600 fibers at a 1:1 (75:25):(85:15) PLGA co-
polymer ratio. These numbers represented 4.1%, 8.3% and 17% of the proposed conduit’s luminal 
cross-sectional area respectively. These tubes were then loaded with DRG, which were allowed to 
grow as described above and evaluated for outgrowth onto the fibers within the PE tube.  
 
Assembly of the Nerve Repair Conduit for Implantation: 
The extruded fibers and knitted/electrospun conduit sheath were fabricated separately to facilitate 
sterilization for implantation. Immediately prior to implantation, 75:25 and 85:15 PLGA fibers 
(n=150 of each type) were threaded into the lumen of the conduit sheath and a solution of alginate 
containing the bio-factor components (50 ng/ml each) was prepared. Crosslinking of the 
alginate/biofactor solution with CaCO3, was initiated in situ by Gluconolactone after which it was 
injected into the assembled conduit and allowed to set overnight at 4oC for implantation the next day. 
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Control conduits, consisting of the knitted/electrospun sheath with the alginate hydrogel and no fibers 
or biofactors were also assembled for implantation.  
 
Surgical Implantation of Nerve Repair Conduit:  
Eight male Sprague Dawley Rats (8 weeks of age) were anesthetized by inhalation of a mixture of 
isoflurane 1% v/v and oxygen (2L/min). Rats were placed on warming pads to maintain body 
temperature and anaesthesia was maintained throughout the whole procedure by nose cone 
inhalation. The fur was shaved, cleaned with ethanol (swab), prepped with 10% iodine cutaneous 
disinfectant (Povidone, Pfizer) and a dorsal gluteal incision made through the skin. The sciatic nerve 
was exposed within the hamstring component of the thigh and a 12 mm section of nerve was 
removed 10 mm distal to the inferior border of the piriformis muscle. Care was taken to preserve 
branches to the extensor musculature of the thigh.  A conduit, of the same size as the removed nerve 
section was sewn into the nerve to bridge the gap. Four rats were implanted with empty conduits, 
whilst the other four were implanted with conduits containing fibers and NT-3 based hydrogel 
neuromatrix as specified in the preceding text. Three sutures were sewn through the epineurium of 
the distal and proximal stumps to hold the conduit in place by the conduit sheath wall using 10-O 
nylon. The wound was closed in a layered manner with 4-O Viacryl to the fascia lata and 
subcutaneous tissue while metal (Michel) clips were used to close the skin. The animals were 
allowed to recover before being placed back in their cages and given Bactrim (0.2 mg/ml, 90 µg/g) 
for 24 hours post procedure. All surgical procedures were carried out using sterile techniques and 
were approved by an institutional ethics committee (SVHM AEC approval #80/07). 
 
Analysis of Axotomized Rat Sciatic Nerve Regeneration 
Over the four-week period of implantation, the rats were monitored for signs of discomfort, including 
autotomy of digits from the nerve transection. Autotomy of the axotomized limb occurs as a result of 
the rats feeling pain from the axotomy and an inability for the rat to feel pain in attempting to 
“groom” the perceived site of the pain [62]. Correct nerve resuturation has been shown to 
significantly decrease autotomy in rats [63] and has been previously used by other investigators as an 
assessment of nerve restoration, particularly where conduits have been used as a means of 
accelerating nerve regeneration[64]. The animals were scored for extent of autotomy using an 
autotomy scale from 0-4 where 0 = no evidence of autotomy, 1 = 1 toe affected, 2= 2 toes affected, 
3= 3 toes affected and 4 = 4 toes affected [62]. The results were statistically evaluated using non-
parametric Chi square statistic with a null hypothesis that the number of autotomized digits would not 
differ between rats implanted with empty (non-functional) conduits compared to rats implanted with 
fully functional conduits if the fully functional conduits were not effective.  
 
At the end of the four-week implantation period, the animals were euthanased by a lethal dose of 
sodium pentobarbitone at a concentration of 60mg/ml given at a dose rate of (200mg/kg), 
administered by intraperitoneal injection. At this point, the extent of autotomy was scored by 
counting the number of digits mutilated in each group implanted with neuromatrix-containing 
conduits and compared to rats with conduits containing empty sheaths (no hydrogel and no fibers). 
The animals were then dissected to remove the conduit and approximately 3-4mm of the attached 
distal and proximal nerve. The nerve and conduit was immediately placed in 10% formal saline and 
left for 24 hours, before embedding in paraffin. Paraffin sections were cut at 8-10µm, and dewaxed 
through a standard alcohol series. The nerve sections were immunolabelled with rabbit anti-Beta-III 
Tubulin (Covance, Tuj-1 clone, 1:1000 dilution) and alexafluor donkey anti-rabbit (Molecular 
Probes, 1:2000 dilution) antibodies before counterstaining with 200 ng/ml DAPI in PBS (Sigma). 
Sections were cover-slipped in fluorescent mounting media (DAKO) and viewed under fluorescence 
using an Olympus IX70 inverted microscope. Digital images were captured using a SPOT-RT Slider 
camera and SPOT software (Diagnostic Instruments). 
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Results: 
Bio-Affinity of Polymers for Neuronal and Schwann Cell Types:  
Cell numbers were evaluated on each polymer formulation using the MTS assay with data that were 
calibrated to account for inter-cell type differences in inherent cytoplasmic reductase activities 
between the three cell types used. To enable direct comparisons, the “raw” data were expressed 
relative to the reductase activity detected in 5x103 RSC96 cells, which yielded 139% and 122% of the 
reductase activities of 5x103 PC12 and Rat1-R12 cells respectively. The respective capacities of the 
PLGA co-polymer formulations to support neuroregeneration were evaluated using an elimination 
process devised to establish their potential to promote attachment and growth of the functional cells 
(neurons and Schwann cells) of the damaged nerve over the inhibitory cells (fibroblasts) at the site of 
nerve injury: As such, the polymers selected for inclusion into the proposed nerve repair conduit 
would ideally support attachment and growth of neurons and supportative neuroglia (Schwann cells) 
in preference to the growth of inhibitory fibroblasts. Selection of the best polymer formulations for 
inclusion into the conduit lumen was achieved by comparison of relative attachment of neuronal 
(PC12), Schwann (RSC96) and fibroblast (1-R12) rat cell lines firstly at the early attachment stage (6 
hrs), a later attachment/early proliferative stage during the first full proliferation cycle of the cells (24 
hrs), and then after two further proliferative cell cycle periods (72 hrs).  
 
“Immediate” Attachment Affinity of PC12, RSC96 and Rat1-R12 cell lines for Polymers: First 6 hrs: 
Analysis of cell attachment after the first 6 hrs’ exposure to each polymer (Fig 1B) indicated that the 
75:25 polymer formulation supported attachment of PC12, RSC96 and Rat1-R12 essentially to an 
equal extent, but slightly favouring fibroblasts. During this time however, statistically significant 
differences in favour of neuronal (p<0.01) and Schwann (p<0.005) cell lines’ attachment over 
fibroblasts were observed on the 85:15 PLGA formulations. Schwann cell attachment to the 85:15 
formulation was demonstrably higher than the neuronal cell line (p<0.02, Fig 1B). 
 
“Initial” Attachment Affinity of PC12, RSC96 and Rat1-R12 cell lines for Polymers: First 24 hrs: 
The cell attachment dynamics observed after the first 6 hrs differed after the first 24 hrs, a period 
reflective of an early proliferative timepoint (ie < 1 full cell division cycle). At this stage, Schwann 
cell numbers were significantly greater than either neuronal or fibroblast cells on both 75:25 (p<0.03; 
p<0.01 respectively) and 85:15 (p<0.02 and p<0.005 respectively) formulations (Fig 1C). Whilst 
fibroblast numbers on the 75:25 formulation were greater than those of the neuronal cell line 
(p<0.0001), there were greater numbers of neuronal cells than fibroblasts on the 85:15 formulation 
(p<0.01).  
 
“Sustained” Affinity of PC12, RSC96 and Rat1-R12 cell lines for Polymers: First 72 hrs: 
After 72 hrs’ growth, both of the polymer formulations supported significantly greater neuronal and 
Schwann cell line growth to a greater extent than the fibroblasts (Fig 1D). Importantly, there was no 
expansion of fibroblasts on either of these polymer formulations after 72 hrs compared to the 24hr 
timepoint, indicating that protracted fibroblast proliferation would be contained to minimum over 
time on these polymers. In contrast, there were appropriate increases in PC12 and RSC96 numbers on 
both polymers, indicating that these cells’ growth is preferentially supported to that of fibroblasts as 
time progresses. Whilst differences in PC12  and RSC96 cell numbers did not reach statistical 
significance on the 75:25 formulation, both yielded significantly greater numbers compared to the 
fibroblasts (p<0.005 and p<0.009 respectively). Both Schwann and neuronal cells’ numbers were 
significantly greater after 72 hrs’ growth on the 85:15 formulation (p<0.01 and p<0.0003 
respectively) than the fibroblasts (Fig 1D). However, a much greater affinity of this formulation to 
the RSC96 cell line than the PC12 cells was demonstrated by the significantly greater numbers of 
these cells than the PC12s (p<0.01). As suggested by the proposed schematic at the bottom of the 
panels in Figs 1A-D, these results collectively provide a rationale for preferential establishment of 
neuronal and neuroglial with some (but limited) fibroblast cell growth if these polymer formulations 
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were localized to the nerve injury environment. This rationale provided the initial basis for the choice 
of fiber materials for the internal lumen of the nerve repair conduit.  
 
Multi-Modal Synergistic Neurotrophic Fiber/Neurogel Conduit Core Development (in vitro): 
The competitive environment potentially encountered by the three cell types in vivo was investigated 
in vitro using Dorsal Root Ganglion (DRG) explants. These explants contain a multicellular in vitro 
environment that includes sensory neurons, Schwann cells and fibroblasts and thus represent (at least 
to some extent) the competitive cellular environment existent at the site of nerve injury. Several 
insights into the potential behaviour of regenerating nerve were thus obtained using this system: 
Firstly, DRG neurite outgrowth and Schwann cell migration on a substrate devoid of fibers occurred 
in a radial manner with no overt directional control (Fig 2A). In contrast, using a platform with 
PLGA fibers (75:25 or 85:15) attached on a supporting background coated with laminin [45;46], both 
axonal outgrowth and Schwann cell migration were observed to follow a linear path dictated by the 
direction of the fibers (Fig 2B). Importantly, the Schwann cells were seen to migrate and grow along 
the fibers and direct the extending axonal projections, giving rise to the possibility that in vivo, 
Schwann cell-mediated trophic signalling and myelination of axons would be facilitated on the fibers. 
This result differs somewhat to the work of others, who showed that whilst neurite growth and 
Schwann cell migration from DRG essentially coincided on laminin-coated 30 µm polypropylene 
filaments, a slightly greater neurite outgrowth than Schwann cell migration was evident [47]. 
However, those studies involved DRG growth within a poly(acrylonitrile-co-vinyl chloride) (PAN-
PVC) tube and as such involved different polymers and are only indirectly comparable with those 
presented here. Thirdly, evaluation of this growth response using immuno-histochemistry for S100β 
(Schwann cell antibody) and nuclear DAPI staining to differentiate Schwann cells (S100β-positive, 
DAPI-positive) from fibroblasts (S100β-negative, DAPI-positive) also confirmed that fibroblast 
activity was a minimal component of the DRG growth behaviour on these fibers, which also guided 
neuronal growth in a linear manner. This was evident in the presence of fibers (Fig 2B), whilst 
absence of fibers on the growth substrate promoted discrete regions of aggregated fibroblast 
deposition that appeared to exclude axonal tracking (“Fb” in Fig 2A).   
 
Multimodal Neuromatrix: BDNF and NT3 are well-characterized neurotrophins that promote 
neuronal outgrowth in vitro and promote a neuroprotective environment in damaged nerve in vivo. 
The authors have previously used polypyrrole (pPy) for controlled delivery of NT3 and BDNF to 
promote the growth of auditory neurons in vitro [65-67]. In this (current) study, the possibility of 
promoting a multimodal synergistic nerve growth response was explored by application of either 
NT3 or BDNF, in conjunction with factors known to promote neuroprotective (LIF), Schwann cell 
trophic (SMDF) and otherwise neurotrophic response (MGF-1) to facilitate effective peripheral nerve 
repair and reinnervation of target muscle. The individual effects of each respective bio-factor on 
neuronal outgrowth were evaluated by exposure of primary pseudo-bipolar neurons dissociated from 
DRG and grown in vitro over 48 hours in the presence of each bio factor, after which the extent of 
neurite extension on individual neurons (100 to 120 neurons per factor) was measured using image 
analysis (ImageJ/NeuronJ sub-program)[60]. In the first instance, MGF-1 had no effect on its own on 
axonogenesis. The results of dissociated DRG neurite growth under the influence of Laminin and on 
Laminin in the presence of BDNF, NT3, LIF and SMDF respectively, are presented in Table 1. These 
results formed the basis for selection of the specific neuromatrix configuration: In the first instance, 
NT3 promoted 50% more neurite outgrowth than did BDNF (p<0.001; t). In addition, LIF displayed 
some neurotrophic activity alone compared to cells grown on Laminin, whilst SMDF did not. These 
results showed that the multimodal principle proposed in this study, utilizing different molecular 
pathways to promote a synergistic effect on nerve regrowth (Fig 1) would best involve the 
stimulation of Trk receptor pathways using NT3 and gp130 pathways via LIF because there appeared 
to be a robust difference in the extent to which these two factors exerted their neurotrophic effect 
(p<1x10-6).  On the other hand the extents of BDNF and LIF neurotrophic effects respectively, which 
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likewise acted via Trk and gp130 receptor pathway activation, did not differ statistically from each 
other (p<0.06, not significant; NS, Table 1). The final aspect that determined NT3 as the “preferred” 
neurotrophin component of the multimodal neuromatrix involved consideration of the neuromatrix’ 
requirement for SMDF-mediated promotion of Schwann cell migration and proliferation to provide a 
more native neurotrophic effect: This requirement is facilitated by the reported enhancement of 
Schwann cell migration by NT3, compared to BDNF, which inhibits Schwann cell migration [68].  
 
The in vitro neuromatrix variants containing either NT3 or BDNF were validated using a model 
conduit core prior to fabrication and implantation of the conduit into axotomized rats. This modelling 
utilized a 2mm diameter polyethylene tube into which fibers and alginate hydrogel were set in the 
lumen (Figs 2C to 2E). In the first instance, this confirmed that growth through the 0.75% alginate 
matrix occurred to a greater extent and in a linear guided manner in the presence of fibers, compared 
to alginate devoid of fibers where the DRG did not grow into the gel at all. It was found also that of 
tubes containing 150, 300, and 600 fibers at a 1:1 ratio of (75:25):(85:15) PLGA fiber ratio, 300 
fibers optimally allowed ingress of Schwann cells into the hydrogel. Greater numbers of fibers (600) 
were difficult to load into the lumen and when assembled did not permit ingress of DRG axons and 
Schwann cells, whilst 150 fibers were loosely and non-uniformly placed within the lumen. The 300 
fibers identified here as optimal in vitro occupied a 8.3% of the cross-sectional area of the lumen, 
consistent with others’ finding that a cross-sectional area of 7.5% provided a workable compromise 
between in vivo support of effective nerve repair and mechanical integrity and structural uniformity 
of the lumen environment [61]. Whilst the presence of fibers guided axonal outgrowth, it was evident 
that in the absence of stimulation from growth factors, Schwann cell migration and any consequential 
possible axonal outgrowth from the DRG were limited (Fig 2A).  In addition, these experiments 
provided rationale for the inclusion of MGF-1, whose inclusion as a neuromatrix component with the 
other factors significantly improved incursion of DRG growth into the hydrogel/fiber core than with 
neurotrophic combinations in which MGF-1 was omitted (Data not shown). This result was 
interesting, given that MGF-1 alone did not promote any overt improvement in nerve growth into the 
hydrogel/fiber matrix over that observed in the alginate/fiber matrix in absence of growth factors. 
This result suggests that there is some augmentation of neurotrophic effects of the other biofactors by 
the MGF-1. Furthermore, this may be related to pathways that mediate in the selective 
neuroprotective activity of MGF-1 on motor neurons rather than sensory neurons as found in 
DRG.[69] This latter point is important in that the inclusion of MGF-1 potentially provides a multi-
modal synergistic neuroprotective effect that targets the various sensory and motor neurons, in 
addition to Schwann cells found in peripheral nerve and as such, gives rise to an environment capable 
of providing tightly controlled neuroregeneration. 
 
Application of the Nerve Repair Conduit to Sciatic Nerve Axotomy: 
The essential process of fabrication and implantation of the nerve repair conduits until harvest is 
outlined in Figure 3: After extrusion of 75:25 and 85:15 PLGA fibers (Fig 3A) and production of the 
electrospun conduit sheath (Figs 3B and 3C), the “neuro-optimized” nerve repair conduit with 
controlled pore sizes of around 2 µm (Fig 3D) was assembled under sterile conditions with 150 of 
each type of fiber (300 fibers in total), an hydrogel containing NT3, SMDF, MGF-1 and LIF (50 
ng/ml of each) and allowed to cross-link overnight at 4oC (Figs 3E and 3F).  
 
The assembled nerve repair conduits (Figs 3A to 3F) either with or without the complete NT-3-based 
hydrogel, and 150 75:25 and 150 85:15 PLGA fibers were implanted into rats (n=4) with axotomized 
sciatic nerves (Fig 3G) for a period of 4 weeks after which the extent of autotomy (self-mutilation of 
paws in the implanted limb) was scored, the animals given lethal doses of sodium pentobarbitone and 
the nerve grafts removed (Fig 4A) for analysis. After removal, the sciatic nerve portions were 
analysed for axonal outgrowth and Schwann and fibroblast cell migration into the conduit lumen. 
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Initial examination of the conduits in each rat after the 4-week implantation period revealed patent 
sciatic nerve proximal and distal to the nerve repair conduit implantation site only in animals with 
conduits containing the fully configured neuromatrix. An example of this is shown in Figure 4A. In 
addition, immunohistochemical analysis longitudinally along the length of the nerve injury and 
implanted nerve repair conduit indicated that neuronal outgrowth had extended to (Fig 4C), within 
(Fig 4D) and into the sciatic nerve distal to the axotomy (Fig 4E). Further immunohistochemical 
examination of the nerve tissue within the conduit revealed that in addition to axonal outgrowth into 
and beyond the conduit, at least some of the repaired axons were myelinated (Fig 5B). These results 
were consistent within all of the conduits harvested from the implanted rats.  
 
During the 4 week implantation period, the rats were monitored daily for behavioural signs of 
distress and the effects of the sciatic nerve axotomy. At the point of euthanasia and removal of the 
conduit, autotomy of the axotomized limb was scored and compared in rats implanted with empty 
“sham” conduits and in rats implanted with fully assembled conduits. Significantly reduced levels of 
autotomy were observed in rats implanted with conduits containing the fully-configured neuromatrix 
compared to rats implanted with conduits containing just the conduit sheath (Fig 5C, p<0.04; χ2), 
This result is consistent with others’ finding that silicone cuffs containing PLA fibers promoted 
significantly more effective nerve lesion repair in vivo than did silicone cuffs without fibers [61].  
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Discussion: 
This study investigated the material, structural and biochemical design of a conduit for the repair of 
damaged peripheral nerve using the axotomized sciatic nerve rat model. The study specifically 
evaluated commercially available, regulatory body (FDA)-approved materials for use in the conduit 
on the basis of their potential to select for the growth of key functional cell types (neurons and 
Schwann cells) likely to be encountered at the site of nerve injury in preference to the growth of 
fibroblasts. This selective principle gives rise to the possibility that inhibitory (fibroblast) cellular 
activity may be limited to satisfactory levels simply by virtue of inherent bionic properties of the 
materials from which the conduit was fabricated. This study aimed to build this concept into a 
conduit that would facilitate effective peripheral nerve repair through compartmentalizing the key 
functional components of the neuro-regenerative process by providing them with “preferred” 
substrata within the conduit lumen. In the first instance, it was determined that PLGA with 75:25 and 
85:15 co-polymer ratios were the optimal formulations for fabrication of conduit fibers that 
facilitated Schwann cell attachment, migration and growth as a conditioning bio-activity for axonal 
outgrowth, much better than they facilitated inhibitory fibroblast growth. Whilst the specific reasons 
for this are unclear, it is possible that at least part of the reason for this relates to tissue compliance 
mediated by a softer surface [70;71] presented on the formulations containing greater amounts of 
glycolic acid than lactic acid alone and as the respective formulations started to degrade with time. 
This possibility is highlighted by the progressively increased bioaffinity of the PC12 and RSC96 cells 
over a 72 hr growth period compared to the lack of growth over this period observed by the Rat1-R12 
cells.  
 
It is important to note the competitive interrelationships between the three cell types at the site of 
nerve injury and the roles that each have in effective nerve regeneration: In the context of nerve 
repair in vivo, the neuronal attachment aspect does not require a proliferative component, but rather, 
involves axonal sprouting and extension over a prolonged period and is supported by Schwann cell 
activity.  The strong bio-affinity dynamics showing a predominant RSC96 Schwann cell attachment 
at all stages over the first 72 hrs (Fig 1) are thus of relevance given that this potentially establishes 
early Schwann cell support for neuronal outgrowth on both polymers when implanted. Importantly, 
in this context, the affinity of the RSC96 cells for 85:15 PLGA is significantly greater than that of the 
Rat1-R12 fibroblasts throughout the 72 hr period and is accompanied by likewise greater affinity of 
the neuronal PC12 cells for the polymer than that shown by the fibroblast cells at all stages. This 
establishes the rationale (presented by the schematics in Figs 1A to 1D) that the foundation biological 
activity on 85:15 fibers within the lumen of a nerve repair conduit at the site of transection would be 
axonal extension, supported by rapid “immediate” Schwann cell migration and proliferation. In this 
regard, the initial preference of the fibroblasts compared to the Schwann cells (Fig 1B) and the 
neuronal cells (Figs 1B and 1C) for the 75:25 PLGA formulation can be deemed negligible from a 
neuro-regenerative context given that the fibroblasts appear to enter a dormant (non-proliferative) 
state in latter stages (Figs 1C and 1D) in deference to Schwann and neuronal PC12 cells, which 
continue to populate the 75:25 surface. This rationale finds further support from the directional 
migration and growth of Schwann cells in conjunction with axonal extension of sensory neurons 
without excessive establishment of fibroblast populations from DRG explants on the fibers (Fig 2B). 
Likewise, these findings are consistent with others’ reporting of similar neurite/Schwann cell growth 
dynamics on polypropylene fibers in vitro [47]. 
 
The Alginate/Fiber neuromatrix provided additional support over the individual pro-neural effects of 
the synthetic polymer components: The fibers in themselves were able to support guided Schwann 
cell migration and neuron outgrowth (Figs 2A compared with 2B), as evidenced by incursion of 
axons into the alginate when fibers were incorporated (Figs 2C to 2E), but not into the alginate 
hydrogel on its own (data not shown). Minimal in-growth achieved with neuromatrix in the absence 
of trophic factors (Fig 2C), was improved by addition of combinations of BDNF (Fig 2D) or NT-3 
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(Fig 2E) with LIF, SMDF and MGF-1. Of all combinations evaluated, by far the best neuro-
regenerative effects were observed with full combinations utilizing BDNF/SMDF/LIF/MGF-1 (Fig 
2D) or NT-3/SMDF/LIF/MGF-1 (Fig 2E) cocktails. Of these, the NT-3 variant conduit promoted the 
greatest growth response in DRG ex vivo. The inclusion of MGF-1 peptide in these configurations 
was observed to promote vast improvements in the extent of axonogenic incursion into the matrix 
along the fibers compared to biofactor cocktails from which the MGF-1 had been omitted. Again, 
others’ observation that inclusion of biological factors (Laminin or Fibronectin) increased neurite 
outgrowth and Schwann cell migration within simulated nerve repair conduits using DRG explants in 
vitro, provides indirect support for the results presented here [47]. 
 
The final nerve repair conduit was thus assembled using the NT-3 version of the neuromatrix and 
implanted into axotomized rat sciatic nerve (Figs 3A to 3G) for a period of four weeks to repair a 12 
mm gap. During this time, daily monitoring of general activity of the rats with the implanted conduits 
indicated some functional improvement albeit incomplete, in the implanted legs, as evidenced by 
progressive ambulatory improvement. This qualitative observation was supported by significantly 
reduced extent of autotomy in the axotomized legs of animals implanted with conduits containing the 
full neuromatrix compared to animals with conduits containing empty conduit sheaths (Fig 5C). 
These results concur with those of others that correlated autotomy with ineffective nerve repair due to 
anaesthesia of the paw on the nerve-transected limb [72] and suggest that the fully-configured 
conduit (ie sheath, NT-3/SMDF/LIF/MGF-1  neuromatrix hydrogel and fibers) restores some level of 
sensation in the axotomized limb (Fig 5B).  
 
After the four-week implantation period, the sciatic nerves bridged by the nerve repair conduit were 
retrieved from the implanted rats, revealing patent nerve at regions proximal and distal to the conduit 
at the site of axotomy (Fig 4A). Immunological analysis of the bridged nerve segments indicated that 
the nerve upstream of the conduit was indeed patent, (Fig 4B), entered the nerve repair conduit (Fig 
4C), and that axons grew through (Fig 4D) and beyond (Fig 4E) the conduit. This analysis also 
indicated that the PLGA guidance fibers within the neuromatrix were still hard, leaving “void” 
regions where the cryo-microtome encountered excessive resistance during sectioning. Similar results 
were reported by others with PLA fibers, which were clearly intact after a ten-week implantation 
period [61]. This aspect of the two materials’ incorporation into nerve repair conduits represents a 
major challenge to their effectiveness, given the specific requirement of a relatively soft substrate for 
neurodifferentiation and neurite outgrowth demonstrated by others [70;73;74].  Immunohistological 
examination using βIII Tubulin (βIII-T) and peripheral myelin protein (PMP) showed the presence of 
myelinated axons within the lumen of the conduit, and is consistent with others’ having shown that a 
silicone cuff with PLA fibers of comparable dimensions to the conduit fabricated in this study 
support effective nerve regeneration in vivo [61].  
 
Collectively, along with the above-mentioned and other similar studies within the literature, our 
results support the possibility that the full NT-3 configuration of our nerve repair conduit restored 
some sensation in the axotomized limbs through support of effective repair of the transected sciatic 
nerve. However, more detailed functional analyses (eg nerve conduction) are still required to fully 
quantify the extent of functional repair promoted by the conduit designed in this study.  
 
This study has described the design and development via a relatively rapid in vitro process of a 
highly engineered multimodal, multicomponent nerve repair conduit and its application in vivo, to 
repair a 12 mm gap a rat sciatic nerve axotomy model of peripheral nerve trauma. Whilst the size of 
the gap repaired in this study largely reflects repairs achieved by others using the axotomized rat 
model [37;38;61;75;76], there have been some studies that have achieved repair of larger nerve gaps 
[61;77] using different materials and different configurations. However, these studies have 
universally demonstrated issues with their specific configurations that mitigate their potential for 
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clinical application. Nevertheless, collectively there remains good rationale for further development 
of synthetic nerve conduits that will ultimately provide nerve repair as good or even superior to 
conventional nerve grafts [78-82]. It is clear that further work is required to improve their efficacy, 
particularly for the repair of longer nerve gaps [79;83] and the novel multimodal nerve repair concept 
applied in this study has shown an initial efficacy that may be further improved by inclusion of 
materials with better tissue compliance, fabricated into fiber formats with better physical and 
molecular facilitation of proper nerve repair. Likewise, further analysis of the extent of functionality 
gained through use of the nerve repair conduit described in this work will highlight the path towards 
improving this initial design towards clinical applicability.    
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Figure Legends: 
Figure 1. A schematic of the cut nerve/conduit interface is presented in panel (A) at t=0 hr after 
implant. The relevant nerve components represented on the schematic are axons (green lines), 
Schwann cells (red circles) and fibroblasts (blue circles), whilst conduit components shown are 85:15 
and 75:25 PLGA (grey and black lines respectively) and alginate hydrogel (white spaces in the 
conduit section). The projected/expected in vivo growth behaviour of the three nerve components, 
based on relative in vitro affinities of representative nerve cell types to the 75:25 and 85:15 PLGA 
formulations over a 72 hr period is outlined schematically below the graphs through 1B to 1D. The 
graphs depict the affinity of the 75:25 and 85:15 polymers to PC12 neuronal, RSC96 Schwann and 1-
R12 fibroblast cells at the early “immediate” attachment (6 hrs) stage (B), an early proliferative 
“initial” attachment (24 hrs) stage (C), and a later proliferative “sustained” attachment (72 hrs) stage 
(D). The strong affinity of the 75:25 and 85:15 polymers to the RSC96 Schwann cells potentially 
establishes a trophic basis for axonal outgrowth via early Schwann cell attachment predominantly on 
the 85:15 fibers and to a lesser degree on the 75:15 fibers, but with some competition from the 
fibroblasts on the latter (fiorst 6 hrs, B). The pro-neurogenic environment established at the 
immediate stages of nerve re-growth within the conduit lumen would thus be maintained over the 
first 24 hrs, with a slight consolidation of this effect via increased affinity of the Schwann cells for 
the 75:25 polymer and increased affinity for neuronal attachment on the 85:15 polymer compared to 
fibroblasts (C). Over the next 48 hrs, the original attachment profile is further consolidated and 
augmented by a significant drop in the relative proliferative affinity of fibroblasts on both polymers 
(which do not proliferate over this time). This combines with increased neuronal attachment on the 
75:25 and 85:15 polymer formulations with undiminished (strong) affinity of the Schwann cells for 
both formulations. The added trophic environment of the hydrogel for the support of Schwann cell 
and neurotrophic/neuroprotective activities provides further bias towards a preferential neuro-
regenerative outcome selectively promoting Schwann cells and axonal outgrowth in preference to a 
cell-mediated fibrotic outcome.     
Figure 2. Dorsal Root Ganglia (DRG) were grown on flat laminin-coated substrate (A) and the same 
substrate with PLGA (75:25 and 85:15) microfibers [45;46] (B) to evaluate the effect of 
microstructure on the growth of the DRG. The microfibers were seen to promote guided linear 
growth of axons (green, βIII Tubulin) with Schwann cells (red, S100β) juxtapose to the growing 
axons. Regions of fibroblast growth were defined by DAPI staining in absence of S100β (Fb) and in 
accordance with previous observations using cell lines (Fig 1), showed that support of fibrogenic 
growth was likely to be minimal compared to neural and neuroglial growth if these materials were to 
be incorporated into a nerve repair conduit. The DRG were also grown for one month in polyethylene 
tubing containing PLGA laminin coated fibers and 0.75% alginate (C to H) to simulate the 
neuromatrix lumen of the proposed nerve repair conduit. The panels show fluorescent labelling of 
Schwann cell nuclei which is visible in the panels as very bright white dots. This highlights the extent 
to which the Schwann cells migrate/grow from the DRG during the month period for which they 
were grown. Required concentrations of each respective bio-factor were optimized in separate in 
vitro experiments prior to finalization of the bio-factor cocktail within the neuromatrix alginate 
hydrogel (data not shown). Neuromatrix versions shown are with no growth factor (C), 50 ng/ml of 
BDNF, SMDF, LIF, and MGF (D), 50 ng/ml NT3, SMDF, LIF, and MGF (E),. Cells were fixed with 
4% paraformaldehyde and permeabilized with 0.02% Triton-X100.  Pictures show DAPI staining of 
cell nuclei and the hydrogel shown to most optimally promote neurogenic activity contained 50 
ng/ml NT3, SMDF, LIF, and MGF (E), as evident by the greatets degree of Schwann cell migration 
from the DRG.   
Figure 3. The process of the nerve repair conduit engineering consisted of fiber extrusion (A), 
knitting of the conduit infrastructure using PLA (B), electrospinning a PLA membrane on the outside 
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of the knitted sheath (C) with controlled pore size of approximately 2 µm (D). The full conduit 
contained fiber components selective for nerve growth guidance and Schwann cell growth over the 
proliferation of fibroblasts (E), with the internal guidance fibers provided separately to the conduit to 
allow the assembly with a fresh multimodal hydrogel containing growth factors (final configuration 
with MGF-1, LIF, NT-3 and SMDF) (F) immediately prior to surgical implantation (conduit 
indicated by the black arrow) into rats with axotomized sciatic nerves (G). 
Figure 4. The conduits were implanted in the rats for a period of four weeks after which they were 
removed. Initial examination revealed patent nerve both proximal and distal to the repaired axotomy 
site (A) and immunohistological assessment (βIII Tubulin, axons; Red; DAPI Schwann cell nuclei) 
indicated the presence of axonal tissue in the treated nerve before (B), at the entry (C) within the mid-
section (D) and outside distal (E) to the conduit. There were void regions (Void; V) that resulted 
from the residual hardness of the polymers used to make the fibers and were generated during 
microsectioning. Address of this aspect with more tissue-compliant polymers stands to greatly 
improve the effectiveness of future versions of the nerve repair conduit. The dotted line represents 
border edges of the conduit.   
Figure 5. Myelinated axons were observed within the lumen of the nerve repair conduits implanted 
in the axotomized rats. Using βIII Tubulin (red) and peripheral myelin protein (PMP; green) 
myelinated axons can be observed within the nerve tissue (A). Myelinated axons were observed 
within the proximal mid-sectional (B) and distal regions of the Nerve repair conduits implanted in the 
rats. (C). The level of autotomy of rats’ limbs implanted with either empty (sham; n=4) or fully 
assembled conduits (n=4) revealed that the rats with fully assembled implants performed less 
autotomy than did rats with “empty (sham)” conduits that did not contain fibers or neuromatrix. This 
indicated that the fully assembled conduits restored sufficient sensation of pain to prevent excessive 
autotomy in the implanted recipient subjects. Abbreviation (B):- NeRPS=Nerve Repair Polymer 
Scaffold. 
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